Here are the top TSX stocks that saw a decent correction lately. Let’s see which of them offers a worthwhile opportunity.The post 5 High-Growth TSX Stocks That Have Recently...
Tilray announced that majority holding stockholders approved an increase in the number of authorized shares of its common stock.Since the merger which closed in May 2021, the...
Here's why Tilray (TSX:TLRY)(NASDAQ:TLRY) remains one of the top cannabis stocks long-term growth investors may want to watch right now.The post Cannabis Stocks: If the Rally...
The stock is trading below both the 50-day moving average and the 200-day moving average, indicating the sentiment in the stock has been bearish.
Tilray (NASDAQ:TLRY), now the biggest cannabis company in the world is currently also offering up stellar performances.In the last year, after being bought by Canadian-based Aphria...
Following its recent merger with fellow Canadian cannabis producer Aphria, Tilray (TLRY) made no secret of its ambition to gain a foothold in the lucrative U.S. pot ma...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Buy | Neutral | Strong Sell | Sell |
| Technical Indicators | Buy | Strong Buy | Strong Buy | Strong Sell | Buy |
| Summary | Strong Buy | Strong Buy | Buy | Strong Sell | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.09 | 0.00 | 0.00 | -0.01 | -10.53% | 3.00K | TSXV | |||
| 2.79 | 2.79 | 2.68 | +0.030 | +1.09% | 3.51M | Toronto | |||
| 30.52 | 31.03 | 30.46 | -0.41 | -1.33% | 297.15K | Toronto | |||
| 9.96 | 9.97 | 9.75 | +0.06 | +0.61% | 153.35K | Toronto | |||
| 23.21 | 23.29 | 22.42 | +0.74 | +3.29% | 2.24M | Toronto | |||
| 6.53 | 6.58 | 6.48 | 0.00 | 0.00% | 145.13K | Toronto | |||
| 10.25 | 10.47 | 10.25 | -0.12 | -1.16% | 15.59K | Toronto | |||
| 28.75 | 28.88 | 28.57 | +0.01 | +0.03% | 873.79K | Toronto | |||
| 87.57 | 88.04 | 87.32 | -0.16 | -0.18% | 141.12K | Toronto | |||
| 0.83 | 0.00 | 0.00 | +0.020 | +2.47% | 10.00K | TSXV | |||
| 82.80 | 83.12 | 82.37 | +0.30 | +0.36% | 1.22M | Toronto | |||
| 0.36 | 0.00 | 0.00 | +0.04 | +14.06% | 263.64K | CSE | |||
| 0.07 | 0.00 | 0.00 | 0.0000 | 0.00% | 8.00K | TSXV | |||
| 65.44 | 65.83 | 65.33 | +0.06 | +0.09% | 357.26K | Toronto | |||
| 15.58 | 15.71 | 15.37 | +0.01 | +0.06% | 167.88K | Toronto |
Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.